Literature DB >> 25885127

Solid-pseudopapillary neoplasm of the pancreas: a clinicopathological and immunohistochemical study of 33 cases from a single institution in Southern India.

Shantveer G Uppin1, Monalisa Hui, Venumadhav Thumma, Sundaram Challa, Megha S Uppin, Nagari Bheerappa, Regulagedda Adikesava Sastry, Tara Roshni Paul, Aruna K Prayaga.   

Abstract

BACKGROUND: The clinicopathological and immunohistochemical data of solid-pseudopapillary neoplasm (SPN) from India are limited. Our objectives were to evaluate various histopathological parameters and immunomarkers to elucidate the best possible immunomarker combination that can accurately diagnose these tumors.
MATERIALS AND METHODS: Clinicopathological features of 33 consecutive cases of SPN were retrospectively analyzed. Immunohistochemistry (IHC) was performed on a tissue microarray of 31 of these cases with antibodies to pan-cytokeratin (CK), vimentin, CD 10, E-cadherin, β-catenin, estrogen receptor (ER), progesterone receptor (PR), chromogranin.
RESULTS: Totally, 32 of 33 patients were females with a mean age of 26 years (range 12-62 years). Majority presented with abdominal pain (93.93%) and/or abdominal mass (48.48%). Location in pancreas included tail (14), head (7), body and tail (6), body (5) and neck (1). The mean diameter of the tumor was 8.6 cm (range 0.5-16 cm). Surgical exploration was done in all cases. On IHC, tumor cells were consistently positive for vimentin and negative for chromogranin (100%). CK was positive in 12 cases (38.7%), CD 10 showed perinuclear dot positivity in 14 (45.16%) cases and cytoplasmic positivity in 05 (16.12%) cases. All cases showed loss of membranous staining for both β-catenin and E-cadherin with nuclear positivity in 90.32% and 70.16% cases, respectively. PR was positive in 20 (64.51%) cases, while all of them were negative for ER.
CONCLUSION: Solid-pseudopapillary neoplasm is a tumor commonly affecting young females. Loss of membrane expression of β-catenin and E-cadherin with nuclear positivity can be used confirm the diagnosis of SPN.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25885127     DOI: 10.4103/0377-4929.155305

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  6 in total

Review 1.  Solid Pseudopapillary Neoplasms of the Pancreas: A Surgical and Genetic Enigma.

Authors:  Leon Naar; Despoina-Amalia Spanomichou; Aikaterini Mastoraki; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

2.  Solid Pseudopapillary Neoplasm of the Pancreas: Clinicopathologic Feature, Risk Factors of Malignancy, and Survival Analysis of 53 Cases from a Single Center.

Authors:  He Song; Ming Dong; Jianping Zhou; Weiwei Sheng; Banghua Zhong; Wei Gao
Journal:  Biomed Res Int       Date:  2017-09-28       Impact factor: 3.411

Review 3.  Solid-pseudopapillary Neoplasms of the Pancreas is still an Enigma: a Clinicopathological Review.

Authors:  Attila Zalatnai; Viktória Kis-Orha
Journal:  Pathol Oncol Res       Date:  2019-06-17       Impact factor: 3.201

4.  Clinicopathological and immunohistochemical study of 29 cases of solid-pseudopapillary neoplasms of the pancreas in patients under 20 years of age along with detailed review of literature.

Authors:  Nasir Ud Din; Shabina Rahim; Jamshid Abdul-Ghafar; Arsalan Ahmed; Zubair Ahmad
Journal:  Diagn Pathol       Date:  2020-12-09       Impact factor: 2.644

5.  Solid Pseudopapillary Neoplasm of Pancreas; A Case Series and Review Literature.

Authors:  Babak Mirminachi; Solmaz Farrokhzad; Amir Houshang Sharifi; Sepideh Nikfam; Arash Nikmanesh; Reza Malekzadeh; Akram Pourshams
Journal:  Middle East J Dig Dis       Date:  2016-04

6.  Solid Pseudopapillary Tumor of the Pancreas: One Case with a Metastatic Evolution in a Caucasian Woman.

Authors:  Valentin Lestelle; Claire de Coster; Anthony Sarran; Flora Poizat; Jean-Robert Delpero; Jean-Luc Raoul
Journal:  Case Rep Oncol       Date:  2015-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.